<VariationArchive VariationID="476239" VariationName="NM_001127222.2(CACNA1A):c.2039del (p.Gln680fs)" VariationType="Deletion" Accession="VCV000476239" Version="25" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-15" DateCreated="2017-12-26" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="469437" VariationID="476239">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001127222.2(CACNA1A):c.2039del (p.Gln680fs)</Name>
      <CanonicalSPDI>NC_000019.10:13303831:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13303832" stop="13303832" display_start="13303832" display_stop="13303832" variantLength="1" positionVCF="13303831" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13414646" stop="13414646" display_start="13414646" display_stop="13414646" variantLength="1" positionVCF="13414645" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Q680fs</ProteinChange>
      <ProteinChange>Q681fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.1" sequenceAccession="NM_001127221" sequenceVersion="1" change="c.2042delA">
            <Expression>NM_001127221.1:c.2042delA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.13414646del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.13414646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.13303832del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.13303832del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011569.1" sequenceAccession="NG_011569" sequenceVersion="1" change="g.207629del">
            <Expression>NG_011569.1:g.207629del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000068.4" sequenceAccession="NM_000068" sequenceVersion="4" change="c.2042del">
            <Expression>NM_000068.4:c.2042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000059.3" sequenceAccession="NP_000059" sequenceVersion="3" change="p.Gln681fs">
            <Expression>NP_000059.3:p.Gln681fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.2" sequenceAccession="NM_001127221" sequenceVersion="2" change="c.2042del">
            <Expression>NM_001127221.2:c.2042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120693.1" sequenceAccession="NP_001120693" sequenceVersion="1" change="p.Gln681fs">
            <Expression>NP_001120693.1:p.Gln681fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127222.2" sequenceAccession="NM_001127222" sequenceVersion="2" change="c.2039del" MANESelect="true">
            <Expression>NM_001127222.2:c.2039del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120694.1" sequenceAccession="NP_001120694" sequenceVersion="1" change="p.Gln680fs">
            <Expression>NP_001120694.1:p.Gln680fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001174080.2" sequenceAccession="NM_001174080" sequenceVersion="2" change="c.2042del">
            <Expression>NM_001174080.2:c.2042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001167551.1" sequenceAccession="NP_001167551" sequenceVersion="1" change="p.Gln681fs">
            <Expression>NP_001167551.1:p.Gln681fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023035.3" sequenceAccession="NM_023035" sequenceVersion="3" change="c.2042del">
            <Expression>NM_023035.3:c.2042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075461.2" sequenceAccession="NP_075461" sequenceVersion="2" change="p.Gln681fs">
            <Expression>NP_075461.2:p.Gln681fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_7" sequenceAccession="LRG_7">
            <Expression>LRG_7:g.207629del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_7t1" sequenceAccession="LRG_7t1">
            <Expression>LRG_7t1:c.2042del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_7p1" sequenceAccession="LRG_7p1" change="p.Gln681fs">
            <Expression>LRG_7p1:p.Gln681fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658658789" DB="ClinGen" />
        <XRef Type="rs" ID="1555757523" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.2039del (p.Gln680fs) AND multiple conditions" Accession="RCV000547249" Version="7">
        <ClassifiedConditionList TraitSetID="39917">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1720416">Episodic ataxia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.2039del (p.Gln680fs) AND not provided" Accession="RCV001531294" Version="17">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.2039del (p.Gln680fs) AND Developmental and epileptic encephalopathy, 42" Accession="RCV003317277" Version="2">
        <ClassifiedConditionList TraitSetID="32571">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-19" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-12-26" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10371528</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19486177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25735478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27250579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29926469</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Episodic ataxia with nystagmus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nystagmus-associated episodic ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic ataxia type 2</ElementValue>
                <XRef ID="Episodic+Ataxia+with+Nystagmus/2620" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007163" DB="MONDO" />
                <XRef ID="420932006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellopathy, hereditary paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia, familial, paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive episodic ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar ataxia, paroxysmal, Acetazolamide-responsive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EA2</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APCA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAPA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9602" />
                <XRef ID="9602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="97" DB="Orphanet" />
              <XRef ID="C1720416" DB="MedGen" />
              <XRef ID="MONDO:0007163" DB="MONDO" />
              <XRef Type="MIM" ID="108500" DB="OMIM" />
            </Trait>
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16191" />
                <XRef ID="16191" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32571" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16191" />
                <XRef ID="16191" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1254932" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="2399423|MedGen:C4310716;C1720416" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000656723" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10371528</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19486177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25735478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27250579</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). This variant has not been reported in the literature in individuals with CACNA1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 476239). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln681Argfs*17) in the CACNA1A gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.13414646del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310716" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720416" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7522781" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_001127221.1:c.2042delA|MedGen:C4310716" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004020794" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29926469</ID>
          </Citation>
          <Comment>Variant summary: CACNA1A c.2042delA (p.Gln681ArgfsX17) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 249244 control chromosomes (gnomAD). c.2042delA has been reported in the literature in 2 sisters affected with episodic ataxia and intellectual deficiency (Humbertclaude_2018). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29926469). Two ClinVar submitters have assessed the variant since 2014: both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127221.1:c.2042delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310716" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3437114" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-07-10">
        <ClinVarSubmissionID localKey="109546|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001746324" DateUpdated="2024-07-15" DateCreated="2021-07-10" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="C" referenceAllele="CT" start="13414645" stop="13414646" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7522781" TraitType="Disease" MappingType="XRef" MappingValue="C4310716" MappingRef="MedGen">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1254932" TraitType="Disease" MappingType="XRef" MappingValue="C1720416" MappingRef="MedGen">
        <MedGen CUI="C1720416" Name="Episodic ataxia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1254932" TraitType="Disease" MappingType="XRef" MappingValue="C4310716" MappingRef="MedGen">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3437114" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

